Adolescents and young adults (AYAs) recently diagnosed with cancer are medically vulnerable but little is known about vaccine uptake/intent in this group. AYAs reported on their COVID-19 vaccine uptake/intent. Logistic regression models examined factors associated with vaccine uptake. Higher education (adjusted odds ratio [aOR] = 1.9, 95% confidence interval [CI]: 1.0–3.5) and knowing someone diagnosed with COVID-19 (aOR = 7.2, 95% CI: 1.6–33.5) were associated with increased vaccine uptake. Prior personal diagnosis of COVID-19 (aOR = 0.1, 95% CI: 0.1–0.7) was associated with lower odds of uptake. Targeted interventions may be needed to improve uptake among this group. (ClinicalTrials.gov Identifier: NCT04585269)
WatersAR, KepkaD, RamsayJM, et al.COVID-19 vaccine hesitancy among adolescent and young adult cancer survivors. JNCI Cancer Spectr, 2021; 5(3); doi:10.1093/jncics/pkab049
3.
YasminF, NajeebH, MoeedA, et al.COVID-19 vaccine hesitancy in the United States: A systematic review. Front Public Health, 2021; 9:770985–770985; doi:10.3389/fpubh.2021.770985
4.
ViswanathK, BekaluM, DhawanD, et al.Individual and social determinants of COVID-19 vaccine uptake. BMC Public Health, 2021; 21(1):818; doi:10.1186/s12889-021-10862-1
5.
BaackBN, AbadN, YankeyD, et al.COVID-19 vaccination coverage and intent among adults aged 18–39 years—United States, March–May 2021. MMWR Morb Mortal Wkly Rep, 2021; 70(25):928–933; doi:10.15585/mmwr.mm7025e2
6.
BadrH, ZhangX, OluyomiA, et al.Overcoming COVID-19 vaccine hesitancy: Insights from an online population-based survey in the United States. Vaccines, 2021; 9(10):1100.
7.
MejriN, BerrazegaY, OuertaniE, et al.Understanding COVID-19 vaccine hesitancy and resistance: Another challenge in cancer patients. Support Care Cancer, 2022; 30(1):289–293; doi:10.1007/s00520-021-06419-y
8.
Villarreal-GarzaC, Vaca-CartagenaBF, Becerril-GaitanA, et al.Attitudes and factors associated with COVID-19 vaccine hesitancy among patients with breast cancer. JAMA Oncol, 2021; 7(8):1242–1244; doi:10.1001/jamaoncol.2021.1962
PergamS, BadenL, AbelG, et al.Preliminary Recommendations of the NCCN COVID-19 Vaccination Advisory Committee. Plymouth Meeting, PA: National Comprehensive Cancer Network; 2021.
13.
PergamS, BadenL, AbelG, et al.Recommendations of the National Comprehensive Cancer Network® (NCCN®) advisory committee on COVID-19 Vaccination and Pre-exposure Prophylaxis. Plymouth Meeting, PA: National Comprehensive Cancer Network; 2022.
14.
HardmanS, JacobSA, CovenSL, et al.AYA subspecialty patient and parent views on COVID-19 vaccination. J Adolesc Health, 2022; 70(4):S80–S81; doi:10.1016/j.jadohealth.2022.01.070
15.
WatersAR, AndersonJS, MannK, et al.Drivers of COVID-19 vaccine intent among survivors of adolescent and young adult cancer: A mixed method study. J Cancer Educ, 2022; doi:10.1007/s13187-022-02155-x
16.
Al-JayyousiGF, SherbashMAM, AliLAM, et al.Factors influencing public attitudes towards COVID-19 vaccination: A scoping review informed by the socio-ecological model. Vaccines, 2021; 9(6):548.
17.
AvitzurO. After a COVID diagnosis, when should I get vaccinated?: Neurovirologists on this and other uncharted scenarios on the COVID vaccine. Neurol Today, 2021; 21(3):15–16.
18.
ChuH, LiuS. Light at the end of the tunnel: Influence of vaccine availability and vaccination intention on people's consideration of the COVID-19 vaccine. Soc Sci Med, 2021; 286:114315; doi: 10.1016/j.socscimed.2021.114315
